Linkedin Youtube

MenaQ7® in Media

Nutraingredients-USA.com / June 2017

Vitamin K2 may reverse calcification in people with kidney disease

Nutrition Insight / June 2017 /

Vitamin K2’s Potential

Nutraceuticals World / June 2017 /

Clinical Trial Confirms Need for Vitamin K2 in Hemodialysis Patients

Pharmacy Choice/June 2017 /

New MenaQ7 Vitamin K2 Study Publishes

Nutraceutical Business Review/June 2017 /

MenaQ7 expands Brazil presence with new partner

Nutrition Insight / June 2017 /

Children with Low Vitamin K2 Status at Greater Risk for Frature: Study

Nutraceutical Business Review/June 2017 /

Kids with low K2 status at greater risk of fracture: new study

Nutraingredients-ASIA / November 2017 /

K2 a ‘Novel Therapeutic Target’ for Common Cardiovascular Condition

Vitafoods Insights / December 2017 /

Vitamin K2: Calcium-controlling Cardiovascular Protector

123456789101112131415161718192021222324

Copyright © 2015-2022 MenaQ7®. All Rights Reserved. MenaQ7 Vitamin K2 is a trademark of Gnosis by Lesaffre.  

The statements on this web site have not been approved by the Food & Drug Administration. Our products are not intended to prevent, cure, treat, or diagnose any disease. Absolutely none of the statements on this web site should be construed as medical advice. We recommend all people consult a licensed health care professional before starting any dietary or exercise program.